Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ekes out gains on pharma strength

Mon, 28th Oct 2019 09:17

* FTSE 100 up 0.1%, FTSE 250 up 0.5%

* Astra, GSK offer most support to main bourse

* HSBC falls after profit miss

* Cairn Energy biggest midcap faller
(Adds company news items, changes analyst quote, updates share
moves)

By Muvija M and Shashwat Awasthi

Oct 28 (Reuters) - The exporter-laden FTSE 100
recovered from early losses on Monday despite a rebound in
sterling, boosted by gains in leading drug stocks and as
prospects for a U.S.-China trade agreement powered miners and
industrials.

The blue chip index closed 0.1% higher, lagging peers on
Wall Street and in Europe as a near 4% drop in HSBC
after an underwhelming earnings update, and a slide in dollar
earners, capped gains.

The more domestically-focused FTSE 250 outperformed
with a 0.5% rise ahead of a parliamentary vote on Prime Minister
Boris Johnson's demand for a general election.

AstraZeneca climbed as much 3.6% after saying a
combination of its cancer drug, Imfinzi, along with chemotherapy
helped curb progression of lung cancer in a late-stage study.
The shares ended up 1%.

In the same sector GlaxoSmithKline added 2.2% after
the company said it had begun a late-stage study of its
experimental antibiotic in patients with urinary tract
infections and gonorrhoea.

Gains of between 1.3% and 2.2% in Glencore, BHP
and Anglo American powered the mining sector
, exposed to the international trade scenario, to a
one-month high after U.S. President Donald Trump said he
expected to sign a significant part of a trade deal with China
ahead of schedule.

EARNINGS TARGET

By contrast HSBC shares suffered their biggest
one-day loss in eight months as the bank's third-quarter profit
missed expectations and it dropped its 2020 earnings target amid
macro-economic uncertainties.

The update dragged a sub-index of banks 2.4%
lower.

Financial companies have also had to adjust to a lower
interest rate environment this year as central banks globally
move to loosen monetary policies to cushion an impact from trade
tensions.

To that end, markets are also keeping a close eye on the
U.S. Federal Reserve's meeting this week for more support to the
slowing global economy.

"We see the Fed cutting rates this week and possibly again
next year, as it seeks to provide insurance against a broad
economic slowdown", BlackRock analysts wrote in their weekly
note.

In addition, UK firms face a lack of clarity at home as
lawmakers and Prime Minister Boris Johnson feud over Brexit.
Earlier in the day, the European Union agreed a three-month
flexible delay to the Oct. 31 exit date.

Among midcaps, there was an 8.1% plunge in Cairn Energy
after the oil and gas explorer abandoned an offshore
well in Mexico.

Aston Martin, which has plunged nearly 80% from its
2018 debut, dropped 8.5% after Bank of America Merrill Lynch
downgraded the stock.
(Reporting by Muvija M and Shashwat Awasthi
Additional reporting by Safia Infant in Bengaluru
Editing by Arun Koyyur and David Holmes
)

More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.